Acalabrutinib
Definition: Acalabrutinib, sold under the brand name Calquence, is a anti-cancer medication used to treat various types of non-Hodgkin lymphoma, including mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma. It may be used both in relapsed as well as in treatment-naive settings. Common side effects include headaches, feeling tired, low red blood cells, low platelets, and low white blood cells. source: Wikipedia
- ID
- 763037006
- ID date
- 7 Jan 2022
- Previous ID
- 38993311000001107
- Name
- Acalabrutinib